NICE seeks views on RA drug
The National Institute for Health and Clinical Excellence is seeking views on draft guidance on the use of abatacept (Orencia) for rheumatoid arthritis.
Get unlimited access
As a subscriber you will benefit from:
- Full online and mobile access to news and opinion stories
- Customised email alerts straight to your inbox (30+ alerts available)
- 4,500 practice articles in our archive
- Over £500 worth of CPD learning units